Articles with public access mandates - Radovan VrhovacLearn more
Not available anywhere: 1
Total body irradiation+ fludarabine compared to busulfan+ fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic …
S Giebel, M Labopin, M Sobczyk-Kruszelnicka, M Stelljes, JL Byrne, ...
Bone Marrow Transplantation 56 (2), 481-491, 2021
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 12
Ruxolitinib: a new JAK1/2 inhibitor that offers promising options for treatment of myelofibrosis
A Ostojic, R Vrhovac, S Verstovsek
Future oncology 7 (9), 1035-1043, 2011
Mandates: US National Institutes of Health
Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft‐versus‐host disease
I Bojanic, M Mravak Stipetic, D Pulanic, L Desnica, S Mazic, ...
Transfusion 58 (6), 1494-1499, 2018
Mandates: US National Institutes of Health
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study
F Baron, F Efficace, L Cannella, P Muus, S Trisolini, CJM Halkes, P Fazi, ...
American journal of hematology 95 (7), 749-758, 2020
Mandates: National Fund for Scientific Research, Belgium
High prevalence of small-and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD
E Bilic, V Delimar, L Desnica, D Pulanic, M Bakovic, LM Curtis, ...
Bone marrow transplantation 51 (11), 1513-1517, 2016
Mandates: US National Institutes of Health
Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
Z Perić, L Desnica, N Duraković, A Ostojić, D Pulanić, R Serventi-Seiwerth, ...
Croatian medical journal 57 (1), 6-15, 2016
Mandates: US National Institutes of Health
Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation
E Prenc, D Pulanic, M Pucic-Bakovic, M Pezer, L Desnica, R Vrhovac, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (8), 1615-1622, 2016
Mandates: US National Institutes of Health
Joint and fascial chronic graftvs-host disease: correlations with clinical and laboratory parameters
T Vukić, S Robinson Smith, D Ljubas Kelečić, L Desnica, E Prenc, ...
Croatian medical journal 57 (3), 266-275, 2016
Mandates: US National Institutes of Health
Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
D Pulanić, L Desnica, R Vrhovac, D Nemet, D Wolff, H Greinix, SZ Pavletic
Croatian medical journal 57 (1), 1, 2016
Mandates: US National Institutes of Health
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 …
F Baron, M Stevens-Kroef, M Kicinski, G Meloni, P Muus, JP Marie, ...
Annals of Hematology 97, 1785-1795, 2018
Mandates: National Fund for Scientific Research, Belgium
B regulatory cells and monocyte subpopulations in patients with chronic graft-vs host diseas
A Babić, L Kurić, A Zelić Kerep, L Desnica, A Lelas, M Milošević, ...
Croatian medical journal 62 (2), 154-164, 2021
Mandates: US National Institutes of Health
Significant associations of igG glycan structures with chronic graft-versus-host disease manifestations: results of the cross-sectional NIH cohort study
E Prenc, D Pulanic, M Pucic-Bakovic, I Ugrina, L Desnica, M Milosevic, ...
Frontiers in Immunology 12, 633214, 2021
Mandates: US National Institutes of Health
Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe
R Langer, A Lelas, M Rittenschober, A Piekarska, A Sadowska-Klasa, ...
Frontiers in Transplantation 3, 1332181, 2024
Mandates: European Commission
Publication and funding information is determined automatically by a computer program